🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cigna group executive sells over $2 million in company stock

Published 16/05/2024, 22:28
CI
-

In a recent transaction, Mary T. Agoglia Hoeltzel, the Senior Vice President of Tax and Chief Accounting Officer at Cigna Group (NYSE:CI), sold 5,946 shares of the company's common stock. The shares were sold at a weighted average price of $348.7133, with individual transaction prices ranging from $348.68 to $349.01. The total value of the shares sold amounted to approximately $2.07 million.

On the same day, Hoeltzel also acquired 5,946 shares through an option exercise at a price of $120.895 per share, totaling around $718,841. It is important to note that these transactions do not necessarily indicate a change in the executive's view of the company's prospects, as they could be part of a pre-determined trading plan.

Following the sale, Hoeltzel's direct ownership in Cigna Group stands at 2,594.738 shares, which includes a small number of shares acquired from dividend reinvestment. The transactions were reported in a Form 4 filing with the Securities and Exchange Commission, dated May 16, 2024, for the reporting period of May 14, 2024.

Investors often monitor insider transactions as they can provide insights into how the company's executives view the stock's value. However, these transactions are just one of many factors that shareholders consider when making investment decisions.

Cigna Group, a global health service company, is incorporated in Delaware and has its fiscal year-end on December 31. The company is known for its hospital and medical service plans, operating under the standard industrial classification code 6324.

InvestingPro Insights

Cigna Group's latest insider trading movements come at a time when the company's financial health and market performance are of particular interest to investors. With a market capitalization of $96.39 billion and a P/E ratio standing at 27.3, the company showcases its significant presence in the healthcare industry. Notably, Cigna has demonstrated a robust revenue growth of 11.67% over the last twelve months as of Q1 2024, signaling its capacity to expand and generate income effectively. This is further underscored by the company's impressive revenue of $204.15 billion during the same period.

InvestingPro Tips suggest that Cigna's management has been actively engaging in share buybacks, which often indicates confidence in the company's future prospects and a commitment to delivering value to shareholders. Moreover, the company has a history of rewarding its investors, having raised its dividend for three consecutive years. This consistent performance is reflected in the company's dividend yield of 1.63% as of the latest data, coupled with a dividend growth of 13.82% over the last twelve months as of Q1 2024.

For those looking to delve deeper into Cigna's investment potential, InvestingPro offers additional insights and metrics. Currently, there are 17 more InvestingPro Tips available for Cigna Group, which can be explored for a more comprehensive understanding of the company's financial health and market position. To access these tips and take advantage of real-time data, investors can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/CI.

While insider transactions such as those by Mary T. Agoglia Hoeltzel are important, they represent only a piece of the investment puzzle. By considering the broader financial metrics and utilizing resources like InvestingPro, investors can make more informed decisions that take into account the company's overall performance and market trends.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.